AQP1 expression is downregulated in the salivary glands of patients with SS [29], and the elimination of B cells with rituximab can increase the expression of AQP1 in the myoepithelial cells of patients with SS, as well as the saliva flow rate [30]. The gene discussed is AQP1; the disease is synovial sarcoma.